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Purpose: The goal of this study was to evaluate the clinicopathological and imaging features of 
thyroid nodules surgically diagnosed as hyaline trabecular tumor (HTT), and to assess the role of 
cytology and frozen sections (FS) in the diagnosis of HTT.
Methods: This study included 21 thyroid nodules in 21 patients treated from August 2005 to 
March 2015 (mean age, 53.3 years) who were either diagnosed as HTT or had HTT suggested 
as a possible diagnosis based on cytology, FS, or the final pathology report. Patients’ medical 
records were retrospectively reviewed for cytopathologic results and outcomes during the course 
of follow-up. Sonograms were reviewed and categorized.
Results: Twelve nodules from 12 patients were surgically confirmed as HTT. Ultrasonography 
(US)-guided fine needle aspiration (FNA) was performed on 11 nodules, of which six (54.5%) 
were papillary thyroid carcinoma (PTC) or suspicious for PTC and three (27.3%) were HTT or 
suspicious for HTT. Intraoperative FS suggested the possibility of HTT in seven nodules, of which 
four (57.1%) were confirmed as HTT. US-FNA suggested the diagnosis of HTT in 10 nodules, 
of which three (30.0%) were confirmed as HTT. Common US features of the 12 pathologically 
confirmed cases of HTT were hypoechogenicity or marked hypoechogenicity (83.4%), absence of 
calcifications (91.7%), parallel shape (100.0%), presence of vascularity (75.0%), and probable 
benignity (58.3%).
Conclusion: HTT should be included in the differential diagnosis of solid tumors with 
hypoechogenicity or marked hypoechogenicity and otherwise benign US features that have been 
diagnosed as PTC through cytology. 
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Introduction
Hyalinizing trabecular tumor (HTT) of the thyroid gland is a rare 
neoplasm of follicular cell origin that was initially described by 
Carney et al. [1] This rare form of tumor is commonly circumscribed 
or encapsulated, consisting of polygonal and spindle cells arranged 
in a trabecular pattern and separated by hyalinized stroma [2]. 
Microscopically, this neoplasm shows hyaline contents and nuclei 
with frequent grooves and intranuclear inclusions, mimicking the 
presence of amyloid in medullary thyroid carcinoma (MTC) or the 
nuclear features of papillary thyroid carcinoma (PTC), potentially 
leading to misdiagnosis of this benign tumor as malignant based 
on preoperative fine needle aspiration (FNA) cytology [3-6]. HTT is 
generally accepted to be a benign tumor [7], in which the majority 
of tumors do not present with aggressive behavior such as capsular/
vascular invasion, local recurrences, or distant metastases. 
Considering its benign features, efforts have been made to 
identify ways of differentiating this benign tumor from other thyroid 
malignancies, since the preoperative diagnosis can influence 
the extent of surgery. Several studies have evaluated the role of 
preoperative ultrasonography (US)-guided FNA results [3-6] and 
frozen sections (FS) [8] in predicting the diagnosis of HTT, and for 
the most part have found difficulties in the accurate preoperative 
diagnosis of HTT by cytology or FS. Moreover, since most studies 
have focused on preoperative US-FNA cytology or the intraoperative 
FS results of thyroid nodules ultimately diagnosed as HTT, little is 
known about the final outcome of thyroid nodules for which HTT 
was suggested as a possible diagnosis on cytology or FS. 
The purpose of this paper was to address this gap by evaluating 
the clinicopathological and imaging features of thyroid nodules 
surgically diagnosed as HTT, as well as the role of cytology and FS in 
the diagnosis of HTT.
Materials and Methods
This retrospective study was approved by the Institutional Review 
Board of Severance Hospital, Seoul, Korea. Neither patient approval 
nor informed consent was required for the review of medical 
records, cytopathologic specimens, and sonograms. 
Patients
The medical record database of our institution was searched for 
patients treated from August 2005 to March 2015, for whom HTT 
was suggested as a possible diagnosis either in cytologic reports 
from US-FNA or in pathology reports including FS results from 
surgery. A total of 21 thyroid nodules from 21 patients satisfied 
these inclusion criteria and were included in this study, with 10 
cytology reports, seven FS reports, and 12 final surgical pathology 
reports. The mean age of the patients was 53.3 years (range, 31 to 
80 years). The mean size of the thyroid nodules was 17.7 mm (range, 
3 to 41 mm). Of the 21 patients, three (14.3%) were men and 15 
(85.7%) were women. 
US and US-FNA Procedures
Real-time US was performed using a 7- to 15-MHz linear array 
transducer (HDI5000, Philips Medical Systems, Bothell, WA, USA), 
an 8- to 15-MHz linear array transducer (Acuson Sequoia, Siemens 
Medical Solutions, Mountain View, CA, USA), or a 5- to 12-MHz 
linear array transducer (iU22, Philips Medical Systems). Compound 
imaging was obtained in all images from a HDI5000 or iU22 
machine. 
US and subsequent US-FNA was performed by one of 26 
radiologists (four faculty members and 22 fellows) with 1 to 15 
years of experience in thyroid imaging. US-FNA was performed on 
thyroid nodules showing suspicious US features or on the largest 
mass when none of the multiple thyroid nodules observed showed 
any suspicious US features.
Sonograms of the thyroid nodules were retrospectively reviewed 
by one radiologist (J.H.Y.) with 7 years of experience in thyroid 
imaging. The US features were described according to the following 
categories: internal components, margin, echogenicity, calcifications, 
shape, and vascularity [9]. The internal components were further 
classified into solid, mainly solid (>50% solid content), and 
mainly cystic (<50% solid content). The margins were classified as 
circumscribed or non-circumscribed (i.e., microlobulated or irregular 
margins). Echogenicity was classified as hyperechoic or isoechoic 
(nodules showing hyperechogenicity to isoechogenicity when 
compared to the surrounding thyroid parenchyma), hypoechoic 
(nodules showing hypoechogenicity compared to the surrounding 
thyroid parenchyma), and markedly hypoechogenic (nodules 
showing hypoechogenicity compared to the adjacent strap muscle). 
The presence of calcifications was assessed as no calcifications; 
microcalcifications or mixed calcifications; and macrocalcifications, 
including eggshell calcifications. Shape was classified as parallel 
or non-parallel (larger in the anteroposterior dimension than the 
transverse dimension, ‘taller than wide’). Vascularity was evaluated 
on Doppler sonograms, and was classified as no vascularity, defined 
as the absence of Doppler signals at the periphery or within the 
thyroid nodule; peripheral vascularity, defined as the presence of 
Doppler signals at the periphery of the nodule; and intranodular 
vascularity, defined as the presence of Doppler signals within the 
thyroid nodule with or without the presence of vascular flow at the 
periphery of the nodule. 
Marked hypoechogenicity, non-circumscribed margins, micro-
Thyroid HTT: US, cytology and frozen sections 
e-ultrasonography.org Ultrasonography 35(2), April 2016 133
calcifications or mixed calcifications, and non-parallel shape were 
considered to be US features indicative of malignancy, based on 
criteria that have been presented in the literature [9]. The final 
assessment of the thyroid nodules was probably benign when none 
of the suspicious US features described above were present, and 
suspicious for malignancy when one or more of the suspicious US 
features were present. 
US-FNA was performed at least twice from each thyroid nodule 
using a 23-gauge needle attached to a 2-mL disposable syringe 
without an aspirator. Local anesthesia was not routinely applied. 
The aspirated material was expelled on glass slides and immediately 
placed in 95% ethanol for Papanicolaou staining. The remaining 
material in the syringe was rinsed in saline for cell block processing. 
Cytopathologists were not present during the procedures, and 
additional staining was performed on a case-by-case basis at 
the cytopathologists’ request. One of the seven cytopathologists 
specializing in thyroid pathology interpreted the cytology slides. Until 
December 2009, cytology reports at our institution were divided into 
the following five categories [10]: (1) malignancy, specimen showing 
abundant cells with unequivocal cytologic features of malignancy; 
(2) suspicious for malignancy, specimen exhibiting cytological 
atypia, but insufficient cellularity to make a definitive diagnosis 
of malignancy; (3) indeterminate (including follicular neoplasm or 
Hürthle cell neoplasms), specimen showing cytological findings of 
monotonous cellular population and scanty colloid, lacking papillary 
carcinoma features; (4) benign, including colloid nodules, nodular 
hyperplasia, lymphocytic thyroiditis, Graves‘ disease, and postpartum 
thyroiditis; and (5) inadequate, specimen showing fewer than six 
groupings of well-preserved thyroid cells, each consisting of fewer 
than 10 cells per group [11]. After December 2009, cytology reports 
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from US-FNA of thyroid nodules were based on the six categories 
of the Bethesda System for Reporting Thyroid Cytopathology [12]. 
During both periods, if HTT was considered in the diagnosis, this 
was mentioned in the cytological reports, along with the five or six 
categories that indicated the level of suspicion for malignancy. 
Intraoperative FS
Tissue samples from the resected thyroid nodule and/or the adjacent 
thyroid parenchyma were obtained and processed for FS analysis. 
Frozen tissue samples were cut and stained for histological analysis, 
and the surgical team in the operating room was notified of the 
results. FS results were classified into benign (including HTT), 
malignant, and deferred diagnosis.
Results
During the study period, 12 thyroid nodules in 12 patients were 
confirmed as HTT in the final pathology report. The clinical and 
cytopathologic features of the 12 patients who were diagnosed with 
HTT upon surgery are summarized in Table 1. One patient with HTT 
presented with a palpable mass, while the other 11 patients were 
asymptomatic, with incidentally detected thyroid masses on neck 
US imaging that was performed for a range of reasons. The mean 
age of the patients with HTT was 55.0 years (range, 44 to 70 years). 
Only one of the 12 patients (8.3%) was a man, while the remaining 
11 (91.7%) were women. The mean size of the 12 nodules were 
13.4 mm (range, 3 to 41 mm). Six of the 12 patients with HTT had 
solitary lesions, while the others had multiple coexisting nodules. 
Eleven of the 12 patients underwent US-FNA before surgery, 
and three underwent FNA twice. One patient underwent total 
thyroidectomy with the diagnosis of PTC in the left thyroid gland 
and was incidentally diagnosed with HTT in the right lobe. The 
cytopathologic results were PTC in three patients, suspicious for PTC 
in three patients, atypia of undetermined significance or follicular 
lesion of undetermined significance in one patient, follicular 
neoplasm in one patient, HTT or PTC in two patients, and suggestive 
of HTT in one patient. Among the six patients diagnosed with PTC or 
suspicious PTC based on FNA cytology, five patients were assessed 
as probably benign on US. Six of the 12 patients underwent FS 
during surgery, with the following intraoperative FS results: HTT in 
two patients, follicular adenoma in one patient, PTC or medullary 
carcinoma in one patient, and deferred in in two patients. Ki-67 
staining results were available for nine patients who underwent 
additional immunohistochemical staining (IHC), of whom seven 
(77.8%) had positive Ki-67 results (Fig. 1). Nine patients underwent 
follow-up US (mean follow-up period, 25.5 months; range, 10 to 
72 months), and none had radiologic features suggesting tumor 
recurrence during follow-up. 
US Features of the 12 Thyroid Nodules Diagnosed as HTT
The US features of the 12 nodules diagnosed as HTT are presented 
in Table 2. All 12 nodules had a solid composition. Common US 
features were hypoechogenicity or marked hypoechogenicity 
(83.4%), the absence of calcifications (91.7%), a parallel shape 
(100.0%), and the presence of vascularity (75.0%). None of the 
patients had any pathologic cervical lymph nodes seen on US. 
Seven (58.3%) of the 12 thyroid nodules were assessed as probably 
benign in the final assessment (Figs. 1, 2). 
Table 2. Ultrasonography (US) features of the 12 patients 
surgically diagnosed with hyalinizing trabecular tumor 
US features No. (%)
Composition
     Solid 12 (100)
     Mainly solid 0 (0)
     Mainly cystic 0 (0)
Margin
     Circumscribed 7 (58.3)
     Not circumscribed 5 (41.7)
Echogenicity
     Hyperechoic to isoechoic 2 (16.6)
     Hypoechoic 5 (41.7)
     Markedly hypoechoic 5 (41.7)
Calcifications
     None 11 (91.7)
     Macro- or eggshell 1 (8.3)
     Micro- or mixed 0 (0)
Shape
     Parallel 12 (100)
     Not parallel 0 (0)
Vascularity
     None 3 (25.0)
     Peripheral 5 (41.7)
     Central 1 (8.3)
     Both 3 (25.0)
Cervical lymph nodes on US
     Absent 12 (100)
     Present 0 (0)
Final assessment 
     Probably benign 7 (58.3)
     Suspicious for malignancy 5 (41.7)
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A B
Fig. 1. A 70-year-old woman was surgically diagnosed with hyaline trabecular tumor (HTT).
A. Ultrasonography (US) reveals a 40-mm hypoechoic solid mass (arrows) with relatively benign US features that was assessed as 
probably benign. B. Microscopy shows cells containing nuclear grooves (white arrow) and inclusions (black arrows; H&E, ×200). C, D. 
Immunohistochemical staining for cytokeratin 19 is negative (cytokeratin 19, ×200) (C), but membrane expression for Ki-67 is found (Ki-67, 
×200) (D), confirming the diagnosis of HTT. 
C D
Table 3. Clinical features of seven thyroid nodules with the possibility of hyalinizing trabecular tumor (HTT) suggested on 
intraoperative frozen section (FS) analysis
Case No. Sex Age (yr) Size (mm) FNA FS Pathology
1 F 53 25 r/o PTC HTT HTT
2 F 52 11 HTT vs. PTC HTT HTT
3 F 62 03 HTT r/o HTT HTT
4 F 51 37 Benign Defer, HTT vs. FN FA
5 F 70 41 HTT vs. PTC Defer, HTT vs. PTC HTT
6 F 54 29 HTT Defer, HTT vs. PTC FC, MI
7 M 59 39 AUS/FLUS Defera) Poorly differentiated carcinoma
FNA, fine needle aspiration; F, female; r/o, rule out; PTC, papillary thyroid carcinoma; FN, follicular neoplasm; FA, follicular adenoma; FC, follicular carcinoma; MI, minimally 
invasive; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined significance; M, male.
a)Hyalinizing trabecular tumor, medullary carcinoma, papillary carcinoma (less likely), and poorly differentiated carcinoma (less likely) were included in the differential diagnosis.
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Fig. 2. A 49-year-old woman was surgically diagnosed with hyaline trabecular tumor.
Ultrasonography (A, transverse; B, longitudinal) shows a 15-mm solid nodule (arrows) with marked hypoechogenicity, circumscribed margins, 
parallel shape, and no calcifications. The final assessment of this nodule was probably benign. 
A B
C
Fig. 3. A 36-year-old woman for whom the possibility of hyaline 
trabecular tumor (HTT) was suggested by ultrasonography-guided 
fine needle aspiration. 
A. Sonogram shows a 30-mm mainly solid, isoechoic mass (arrows) 
with circumscribed margins, assessed as probably benign. B. The 
cytology specimen reveals cells containing nuclear grooves (black 
arrows) and inclusions (white arrows) in an abundant hyaline 
background, and the possibilities of HTT and papillary thyroid 
carcinoma (PTC) were suggested in the diagnosis (H&E, ×400). C. 
Pathologic specimen obtained after surgery shows follicular cells 
with a papillary structure, and the tumor was confirmed as PTC, 
conventional type (Papanicolaou, ×200). 
A B
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Outcomes of Intraoperative FS and US-FNA Cytology 
Suggesting HTT 
Intraoperative FS results suggested the possibility of HTT in seven 
thyroid nodules in seven patients, of which four were confirmed 
as HTT, one was follicular adenoma, one was minimally invasive 
follicular carcinoma, and one was poorly differentiated carcinoma 
(Table 3).  
Table 4 summarizes the clinical course of the 10 thyroid nodules 
with the possibility of HTT suggested on US-FNA. The mean age 
of the patients was 53.3 years (range, 31 to 80 years) and the 
mean size of the thyroid nodules was 19 mm (range, 3 to 41 mm). 
Nine of the 10 patients were women. The diagnosis of HTT was 
strongly suggested in two nodules (20.0%) on cytology, while both 
HTT and PTC were included in the differential diagnosis of eight 
nodules (80.0%). Of the two nodules with cytology results strongly 
suggestive of HTT, one was diagnosed as HTT during surgery, and 
one as minimally invasive follicular carcinoma. Of the remaining 
eight nodules with the possibility of both HTT and PTC suggested on 
US-FNA, two were confirmed as HTT, three as PTC (Fig. 3), two as 
follicular variant of PTC, and one as follicular adenoma. 
Discussion
Surgical intervention is necessary when a thyroid malignancy 
such as PTC or MTC is suggested by FNA cytology. Unfortunately, 
the cytologic features of HTT resemble those of PTC, with nuclei 
that have frequent intranuclear inclusions and grooves, and MTC, 
containing abundant hyaline material in stains of the tumor [3-
6]. Due to these overlapping features, the differential diagnosis 
of HTT from PTC or MTC based on FNA cytology alone is very 
challenging [3,4]. Moreover, the correct diagnosis of HTT is made 
more difficult by its rarity; therefore, most surgically proven cases 
of HTT are misdiagnosed as PTC in FNA cytology. Several studies 
have retrospectively reviewed the preoperative cytologic results 
of surgically proven HTT, and the presence of cytological features 
suggestive of HTT have been reported in 58%-100% of cases 
classified as PTC or suspicious for PTC [2,7,8,13]. In contrast, the 
same studies reported that the diagnosis of HTT was suggested in 
preoperative US-FNA in approximately 0%-20% of cases [2,7,8,13], 
which demonstrates the low accuracy of cytology in the diagnosis of 
HTT. The results of our study are similar to previous findings; among 
the eleven patients who underwent US-FNA, 54.5% (6/11) were 
misdiagnosed as PTC, while approximately 27% (3/11) had findings 
that were interpreted as HTT or possible HTT (2/11). 
Table 4. Clinical features of the 10 thyroid nodules with the possibility of hyalinizing trabecular tumor (HTT) suggested on 
ultrasonography-guided fine needle aspiration (FNA)
Case No. Sex Age (yr) Size (mm) FNA FS Pathology IHC on surgery
1 F 62 3 Suggestive of HTT Defer
HTT vs. PTC
HTT -
2 F 54 29 Suggestive of HTT HTT, most likely, 
DDx of PTC
FC, MI CK19 (-)
3 F 31 13 PTC vs. HTT Defer, follicular 
neoplasm
FA -
4 F 33 27 Consistent with PTC 
Cannot rule out HTT
FVPTC FVPTC -
5 F 73 7 Suspicious for PTC
Cannot rule out HTT




6 M 42 20 Consistent with PTC
Cannot rule out HTT
NA PTC, conventional -
7 F 80 9 HTT vs. unusual variant  
of thyroid tumor
NA FVPTC -
8 F 36 30 Suspicious for PTC




9 F 70 41 Consistent with PTC
Cannot rule out HTT
Defer, HTT vs. PTC HTT Ki-67 (+)
10 F 52 11 PTC, solid variant
PTC, follicular variant HTT
HTT HTT Ki-67 (+)
CK19 (-)
FS, frozen section; IHC, immunohistochemical staining; F, female; PTC, papillary thyroid carcinoma; DDx, differential diagnosis; FC, follicular carcinoma; MI, minimally invasive; 
CK19, cytokeratin 19; FA, follicular adenoma; FVPTC, follicular variant of papillary thyroid carcinoma; NA, not applicable.
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HTT is a benign tumor that can be adequately treated with 
thyroid lobectomy alone. However, the misdiagnosis of HTT as 
PTC or MTC on FNA cytology can lead to overtreatment with total 
or subtotal thyroidectomy. Therefore, studies have attempted to 
identify ways of effectively differentiating HTT from PTC or other 
thyroid malignancies, especially using imaging features [2,13]. 
Common US features of the 12 nodules confirmed as HTT in our 
study were hypoechogenicity or marked hypoechogenicity, the 
absence of calcifications, a parallel shape, and the presence of 
vascularity. A final assessment of probably benign was made for 
58.3% of the 12 HTT nodules, consistent with the results of prior 
studies in that the majority of HTT cases showed benign features 
on US [2,13]. In addition, our study included a single case of HTT 
showing macrocalcifications on US, which is quite rare; only one 
study has previously reported a case of HTT showing calcifications 
[14]. Lee et al. [2] concluded that HTT should be included in the 
list of nodules showing discordant US-cytology results, and that 
HTT should be suspected in thyroid nodules diagnosed as PTC on 
cytology but with benign US features. In addition, a relatively high 
proportion (41.7%) of the 12 HTT nodules seen in our study had 
markedly hypoechogenic features compared to the echogenicity 
of the adjacent strap muscle, and all 12 HTT nodules had a solid 
tumor composition. Similarly high rates of marked hypoechogenicity 
were reported by Choi et al. [13], with marked hypoechogenicity 
seen in 29.2% of the HTT nodules. This finding may be useful in 
differentiating HTT from the follicular variant of PTC, which can 
also show relatively benign US features together with the cytologic 
features of PTC [2,13]. Based on our results, HTT should be included 
in the differential diagnosis of solid thyroid tumors showing marked 
hypoechogenicity with otherwise benign US features and cytological 
results indicative of PTC.
With the increased awareness of HTT, attempts to predict the 
diagnosis of HTT based on intraoperative FS have been reported. 
Sung et al. [8] reviewed nine patients diagnosed with HTT and 
found that none of the patients diagnosed as HTT based on FS were 
ultimately diagnosed with other thyroid malignancies such as PTC, 
MTC, or metastatic cancer. In our study, however, the possibility 
of HTT was suggested in intraoperative FS results in seven thyroid 
nodules in seven patients, of which only four were confirmed as 
HTT. The pathologist correctly diagnosed HTT on FS in three cases 
that were finally confirmed as HTT, but the diagnosis was deferred 
in the remaining four cases (57.1%). The final diagnosis of the four 
nodules with deferred results on FS was as follows: HTT in one, 
follicular adenoma in one, minimally invasive follicular carcinoma 
in one, and poorly differentiated carcinoma in one. As Sung et al. 
[8] suggested, intraoperative FS may play an additional role in 
preventing total thyroidectomy by predicting HTT, but it has its 
limitations, since approximately 57.1% of the thyroid nodules with 
intraoperative FS suggesting the possibility of HTT had a deferred 
diagnosis, which may only lead to confusion and the delayed 
treatment of malignant tumors. 
Most studies have focused on the preoperative US-FNA cytology 
results of thyroid nodules finally diagnosed as HTT. To the best of our 
knowledge, this is the first report to present the outcomes of thyroid 
nodules for which HTT was suggested as a possible diagnosis on 
US-FNA cytology. In our study, the possibility of HTT was suggested 
on US-FNA cytology for 10 nodules, of which only three cases were 
eventually confirmed as HTT. These results confirm the previously 
identified difficulties in predicting HTT with US-FNA cytology, and 
also reflect the poor diagnostic performance of US-FNA cytology, 
since only 30.0% of nodules considered suspicious for HTT were 
confirmed as HTT on surgery. In addition, recent studies have shown 
that IHC, such as Ki-67 (MIB-1) and cytokeratin 19, is capable of 
differentiating HTT from PTC [7,15,16]. In our study, approximately 
77.8% of the HTT nodules that underwent IHC were positive for 
Ki-67, consistent with prior studies. Furthermore, as Casey et al. 
[17] reported that Ki-67 may be applied to FNA cytology smears 
for the diagnosis of HTT, we may anticipate future improvement in 
preoperative diagnosis using cytology. 
This study has several limitations. First, this was a retrospective 
study. Second, one radiologist retrospectively reviewed the US 
features of the 21 thyroid nodules included in this study, in order to 
minimize interobserver variability that may occur among different 
radiologists and affect the results. Third, seven cytopathologists 
were involved in the cytopathologic interpretation, including US-
FNA cytology and intraoperative FS, and interobserver variability 
among the readers was not analyzed. Finally, due to the rarity of 
this specific pathologic diagnosis, a limited number of cases was 
included in this study. 
In conclusion, US-FNA cytology and intraoperative FS has limited 
value in the preoperative diagnosis of HTT. HTT should be considered 
in the differential diagnosis of solid tumors with hypoechogenicity 
or marked hypoechogenicity with otherwise benign US features that 
are diagnosed as PTC on cytology.
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